Adult Autoimmune Myopathies (MAIA)

Adult Autoimmune Myopathies (MAIA): Clinical and Immunological Characterization, Constitution of a Patient Library

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04792931

Acronym

MAIA

Enrollment

Registered

2021-03-11

Start date

2022-05-20

Completion date

2030-05-20

Last updated

2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Inflammatory Myopathies

Brief summary

This study corresponds to a monocentric prospective cohort of adult patients presenting a suspicion of idiopathic inflammatory myopathy. It will allows the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood sample, urine, stool and muscle specimen.

Interventions

OTHERdescription of adult autoimmune myopathies

description of adult autoimmune myopathies

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Intervention model description

diagnosis and follow up of adult autoimmune myopathies

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical suspicion of Adult Inflammatory Myopathy * Social security affiliation

Exclusion criteria

* Pregnant and lactating women * Patients unable to consent * Patients refusing to participate in the research. * Patients under legal protection

Design outcomes

Primary

Measure	Time frame	Description
Distribution of lymphocytes subpopulations (B, T and TH-17)	6 months	Distribution of lymphocytes subpopulations (B, T and TH-17) according to the final diagnosis defined by a panel of experts

Countries

France

Contacts

CONTACTDewi GUELLEC

dewi.guellec@chu-brest.fr0230337617

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 26, 2026